THE EFFECTS OF EXENATIDE TREATMENT ON METABOLIC PARAMETERS, GHRELIN, GDF-15 AND FGF-21 IN OBESE TYPE 2 DIABETIC PATIENTS
Kırıkkale Üniversitesi Tıp Fakültesi Dergisi · 2022
DOI: 10.24938/kutfd.1014625 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, 2022. Verfasst von Müge ÖZSAN YILMAZ und 1 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objective
Exenatide and similar drugs which have Glucagon Like Peptide-1(GLP-1) like effects have been used frequently in the treatment of diabetes and obesity in recent years. In this study we aimed to investigate the effects of exenatide on ghrelin, FGF-21 and GDF-15 which are known to be associated with appetite and metabolic disorders.Material and Methods: Thirty patients with Type 2 Diabetes Mellitus with a Body Mass Index of 35 kg/m2 and above who are still ongoing treatment for diabetes but not on target (HbA1c>7%) and exenatide treatment was started were included in the study. Venous blood samples were collected for the measurements of complete blood count, biochemical parameters, HbA1c, ghrelin, FGF-21, GDF-15. After 3 months of treatment initial evaluations and biochemical tests were repeated.
Results
Mean age of the patients was 50.43±10.35 years. Twenty-one (70%) were female and 9 (30%) were male. Mean Hb A1c of the patients was 9.68±2.02%. After 3 months of exenatide treatment a significant decrease in body weight and body mass index was observed (p<0.001). There was also significant decrease in Ghrelin and GDF-15 levels (p<0.001).
Conclusion
Our study is the first study in which these three markers were evaluated together in obese type 2 diabetics. It is thought to be that Ghrelin, FGF-21 and GDF-15 are play role in obesity and type 2 diabetes mellitus pathogenesis together in different ways.
Zitieren
APA
YILMAZ, M. Ö., & ÖZCAN, O. (2022). THE EFFECTS OF EXENATIDE TREATMENT ON METABOLIC PARAMETERS, GHRELIN, GDF-15 AND FGF-21 IN OBESE TYPE 2 DIABETIC PATIENTS. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi. https://doi.org/10.24938/kutfd.1014625
Vancouver
YILMAZ MÖ, ÖZCAN O. THE EFFECTS OF EXENATIDE TREATMENT ON METABOLIC PARAMETERS, GHRELIN, GDF-15 AND FGF-21 IN OBESE TYPE 2 DIABETIC PATIENTS. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi. 2022. doi:10.24938/kutfd.1014625
BibTeX
@article{YILMAZ2022,
author = {YILMAZ, Müge ÖZSAN and ÖZCAN, Oğuzhan},
title = {THE EFFECTS OF EXENATIDE TREATMENT ON METABOLIC PARAMETERS, GHRELIN, GDF-15 AND FGF-21 IN OBESE TYPE 2 DIABETIC PATIENTS},
journal = {Kırıkkale Üniversitesi Tıp Fakültesi Dergisi},
year = {2022},
doi = {10.24938/kutfd.1014625}
}
EUVIMED